CIK 0001671584
- Non-accelerated filer
- Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811567056
- Phone
- +1 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 4 Shares withheld for taxes SVP and CFO gave up 2,170 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 2,710 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Commercial Operations gave up 2,395 shares (to pay taxes)
- 4 Open-market buy SVP Operations bought 5,000 shares at $2.37 ($11,850)
- 4 Open-market buy President and CEO bought 10,000 shares at $2.38 ($23,800)
- 4 Shares withheld for taxes SVP, GC and Corporate Affairs gave up 383 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and CEO gave up 8,373 shares (to pay taxes)
- 4/A Open-market buy President and CEO bought 100,000 shares at $2.93 ($293,000)
- 4 Open-market sale President and CEO sold 100,000 shares at $2.93 ($293,000)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Medical Officer and SVP acquired 13,892 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 10 of 14 · 265 filings